China has a goal of making itself the primary producer of vaccines that are used domestically. To further that aim, the government is encouraging the development of production processes with proprietary IP rights. China is supporting the creation of new strains and technologies within this program.
"It is clear from the plan that the Chinese government intends to create a favorable environment for the growth and development of China's domestic vaccine industry and to achieve self-reliance in the supply of vaccines", law firm Sidley Austin LLP released.
This is another example where the East is rapidly investing to make itself more market competitive. It is also another example of where government policy is used in a strong way to drive economic development and technological advancement in a programmed direction. The US policies need to support similar initiatives in the US biotechnology industry.
Posted by Bruce Lehr Jan 16th 2012.